← Open Payments lookup

MEAGAN OBST: Open Payments

NPI 1841814118 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$591 in 31 payments from 12 companies in 2025. Trend: 2023 $472 · 2024 $528 · 2025 $591

Food & beverage: $591
CompanyPaymentsAmount
ABBVIE INC.11$192
Vanda Pharmaceuticals Inc.4$93
Lilly USA, LLC3$52
Otsuka America Pharmaceutical, Inc.2$42
Astellas Pharma US Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
PFIZER INC.2$34
Edwards Lifesciences Corporation1$31
Axsome Therapeutics, Inc.1$22
Gilead Sciences, Inc.1$19

Products named: VRAYLAR, FANAPT, MOUNJARO, REXULTI, Veozah, CAPLYTA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Auvelity.

Industry payments across KY — which companies pay providers there.